Loading…
6-Substituted and 5,6-Disubstituted Derivatives of Uridine: Stereoselective Synthesis, Interaction with Uridine Phosphorylase, and in Vitro Antitumor Activity
Stereoselective procedures are described for the synthesis of 6-alkyluridines by Lewis acid-catalyzed condensation of (a) trimethylsilylated 6-alkyl-4-alkylthiouracils with 1-O-acetyl-2,3,5-tri-O-benzoyl-β-d-ribofuranose (ABR) and (b) trimethylsilylated 6-alkyl-3-benzyluracils with ABR. The 4-methyl...
Saved in:
Published in: | Journal of medicinal chemistry 1996-04, Vol.39 (8), p.1720-1728 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-a377t-f09c20d8ba8b7e5116421f1cbf9c8f9bea31a2fe2d38c6b3444b6ae9c4461f903 |
---|---|
cites | cdi_FETCH-LOGICAL-a377t-f09c20d8ba8b7e5116421f1cbf9c8f9bea31a2fe2d38c6b3444b6ae9c4461f903 |
container_end_page | 1728 |
container_issue | 8 |
container_start_page | 1720 |
container_title | Journal of medicinal chemistry |
container_volume | 39 |
creator | Felczak, Krzysztof Drabikowska, Alicja K Vilpo, Juhani A Kulikowski, Tadeusz Shugar, David |
description | Stereoselective procedures are described for the synthesis of 6-alkyluridines by Lewis acid-catalyzed condensation of (a) trimethylsilylated 6-alkyl-4-alkylthiouracils with 1-O-acetyl-2,3,5-tri-O-benzoyl-β-d-ribofuranose (ABR) and (b) trimethylsilylated 6-alkyl-3-benzyluracils with ABR. The 4-methylthio group was subsequently removed with the use of 1 N trifluoroacetic acid and the 3-benzyl group by a new modified procedure with the use of the complex BBr3-THF. Furthermore, 6-(hydroxymethyl)uridine (39) and 5-fluoro-6-(hydroxymethyl)uridine (40) were obtained by sequential oxidation with SeO2 and reduction with tetrabutylammonium borohydride of the 6-methyl group of 6-methyluridine (5) and 5-fluoro-6-methyluridine (35), and their corresponding 6-fluoromethyl congeners 41 and 42 were obtained by DAST treatment of 39 and 40, respectively. For all the foregoing nucleosides in the fixed syn conformation about the glycosyl bond, 1H NMR spectroscopy further demonstrated that the pentose rings exist predominantly in the conformation N (3‘-endo). Most of the nucleosides were weak substrates of Escherichia coli pyrimidine nucleoside phosphorylase. Enhanced susceptibility to phosphorolysis was exhibited by two of them, 39 and 41, with 6-CH2OH and 6-CH2F substituents capable of formation of an additional hydrogen bond with the enzyme. The 5-fluoro-6-substituted uridines were the poorest substrates. Cytotoxicities of the nucleosides were examined vs the human tumor cell lines MOLT-3, U-937, K-562, and IM-9, as well as PHA-stimulated human lymphocytes. Two of the analogues, 5-fluoro-6-(fluoromethyl)uridine (42) and 5-fluoro-6-(hydroxymethyl)uridine (40), exhibited cytotoxicities comparable to that of 5-fluorouracil. |
doi_str_mv | 10.1021/jm950675q |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78030906</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78030906</sourcerecordid><originalsourceid>FETCH-LOGICAL-a377t-f09c20d8ba8b7e5116421f1cbf9c8f9bea31a2fe2d38c6b3444b6ae9c4461f903</originalsourceid><addsrcrecordid>eNptkc9uEzEQhy0EKmnhwAMg-QBISFnwv_Xucgst0EqVqEjKgYvl9c4qDrt2antbcuPKY_BqPAkbEiIOnCzN9_k3oxmEnlDyihJGX6_6KieyyG_uoQnNGclEScR9NCGEsYxJxh-i4xhXhBBOGT9CR6UUpaR0gn7KbD7UMdk0JGiwdg3OpzI7s_Gf6hkEe6uTvYWIfYuvg22sgze_vv_A8wQBfIQOzJbj-calJUQbp_jCjUyPZe_wnU3Lv__w1dLH9dKHTacjTP_0tA5_til4PHPbpr0PeLYNtGnzCD1odRfh8f49Qdfv3y1Oz7PLjx8uTmeXmeZFkbKWVIaRpqx1WReQUyoFoy01dVuZsq1q0Jxq1gJreGlkzYUQtdRQGSEkbSvCT9CLXe46-JsBYlK9jQa6TjvwQ1RFSTipiBzFlzvRBB9jgFatg-112ChK1PYc6nCO0X26Dx3qHpqDud__yJ_tuY5Gd23Qzth40DgRJa3YqGU7zcYE3w5Yh69KFrzI1eJqrt4uzhefxBeitiM-3_naRLXyQ3Dj5v4z3m-1xrGH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78030906</pqid></control><display><type>article</type><title>6-Substituted and 5,6-Disubstituted Derivatives of Uridine: Stereoselective Synthesis, Interaction with Uridine Phosphorylase, and in Vitro Antitumor Activity</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)</source><creator>Felczak, Krzysztof ; Drabikowska, Alicja K ; Vilpo, Juhani A ; Kulikowski, Tadeusz ; Shugar, David</creator><creatorcontrib>Felczak, Krzysztof ; Drabikowska, Alicja K ; Vilpo, Juhani A ; Kulikowski, Tadeusz ; Shugar, David</creatorcontrib><description>Stereoselective procedures are described for the synthesis of 6-alkyluridines by Lewis acid-catalyzed condensation of (a) trimethylsilylated 6-alkyl-4-alkylthiouracils with 1-O-acetyl-2,3,5-tri-O-benzoyl-β-d-ribofuranose (ABR) and (b) trimethylsilylated 6-alkyl-3-benzyluracils with ABR. The 4-methylthio group was subsequently removed with the use of 1 N trifluoroacetic acid and the 3-benzyl group by a new modified procedure with the use of the complex BBr3-THF. Furthermore, 6-(hydroxymethyl)uridine (39) and 5-fluoro-6-(hydroxymethyl)uridine (40) were obtained by sequential oxidation with SeO2 and reduction with tetrabutylammonium borohydride of the 6-methyl group of 6-methyluridine (5) and 5-fluoro-6-methyluridine (35), and their corresponding 6-fluoromethyl congeners 41 and 42 were obtained by DAST treatment of 39 and 40, respectively. For all the foregoing nucleosides in the fixed syn conformation about the glycosyl bond, 1H NMR spectroscopy further demonstrated that the pentose rings exist predominantly in the conformation N (3‘-endo). Most of the nucleosides were weak substrates of Escherichia coli pyrimidine nucleoside phosphorylase. Enhanced susceptibility to phosphorolysis was exhibited by two of them, 39 and 41, with 6-CH2OH and 6-CH2F substituents capable of formation of an additional hydrogen bond with the enzyme. The 5-fluoro-6-substituted uridines were the poorest substrates. Cytotoxicities of the nucleosides were examined vs the human tumor cell lines MOLT-3, U-937, K-562, and IM-9, as well as PHA-stimulated human lymphocytes. Two of the analogues, 5-fluoro-6-(fluoromethyl)uridine (42) and 5-fluoro-6-(hydroxymethyl)uridine (40), exhibited cytotoxicities comparable to that of 5-fluorouracil.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm950675q</identifier><identifier>PMID: 8648611</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Antineoplastic agents ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - pharmacology ; Biological and medical sciences ; General aspects ; Humans ; Medical sciences ; Molecular Conformation ; Pharmacology. Drug treatments ; Structure-Activity Relationship ; Tumor Cells, Cultured ; Uridine - chemical synthesis ; Uridine - chemistry ; Uridine - pharmacology ; Uridine Phosphorylase - metabolism</subject><ispartof>Journal of medicinal chemistry, 1996-04, Vol.39 (8), p.1720-1728</ispartof><rights>Copyright © 1996 American Chemical Society</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a377t-f09c20d8ba8b7e5116421f1cbf9c8f9bea31a2fe2d38c6b3444b6ae9c4461f903</citedby><cites>FETCH-LOGICAL-a377t-f09c20d8ba8b7e5116421f1cbf9c8f9bea31a2fe2d38c6b3444b6ae9c4461f903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3048192$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8648611$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Felczak, Krzysztof</creatorcontrib><creatorcontrib>Drabikowska, Alicja K</creatorcontrib><creatorcontrib>Vilpo, Juhani A</creatorcontrib><creatorcontrib>Kulikowski, Tadeusz</creatorcontrib><creatorcontrib>Shugar, David</creatorcontrib><title>6-Substituted and 5,6-Disubstituted Derivatives of Uridine: Stereoselective Synthesis, Interaction with Uridine Phosphorylase, and in Vitro Antitumor Activity</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Stereoselective procedures are described for the synthesis of 6-alkyluridines by Lewis acid-catalyzed condensation of (a) trimethylsilylated 6-alkyl-4-alkylthiouracils with 1-O-acetyl-2,3,5-tri-O-benzoyl-β-d-ribofuranose (ABR) and (b) trimethylsilylated 6-alkyl-3-benzyluracils with ABR. The 4-methylthio group was subsequently removed with the use of 1 N trifluoroacetic acid and the 3-benzyl group by a new modified procedure with the use of the complex BBr3-THF. Furthermore, 6-(hydroxymethyl)uridine (39) and 5-fluoro-6-(hydroxymethyl)uridine (40) were obtained by sequential oxidation with SeO2 and reduction with tetrabutylammonium borohydride of the 6-methyl group of 6-methyluridine (5) and 5-fluoro-6-methyluridine (35), and their corresponding 6-fluoromethyl congeners 41 and 42 were obtained by DAST treatment of 39 and 40, respectively. For all the foregoing nucleosides in the fixed syn conformation about the glycosyl bond, 1H NMR spectroscopy further demonstrated that the pentose rings exist predominantly in the conformation N (3‘-endo). Most of the nucleosides were weak substrates of Escherichia coli pyrimidine nucleoside phosphorylase. Enhanced susceptibility to phosphorolysis was exhibited by two of them, 39 and 41, with 6-CH2OH and 6-CH2F substituents capable of formation of an additional hydrogen bond with the enzyme. The 5-fluoro-6-substituted uridines were the poorest substrates. Cytotoxicities of the nucleosides were examined vs the human tumor cell lines MOLT-3, U-937, K-562, and IM-9, as well as PHA-stimulated human lymphocytes. Two of the analogues, 5-fluoro-6-(fluoromethyl)uridine (42) and 5-fluoro-6-(hydroxymethyl)uridine (40), exhibited cytotoxicities comparable to that of 5-fluorouracil.</description><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>General aspects</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Molecular Conformation</subject><subject>Pharmacology. Drug treatments</subject><subject>Structure-Activity Relationship</subject><subject>Tumor Cells, Cultured</subject><subject>Uridine - chemical synthesis</subject><subject>Uridine - chemistry</subject><subject>Uridine - pharmacology</subject><subject>Uridine Phosphorylase - metabolism</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNptkc9uEzEQhy0EKmnhwAMg-QBISFnwv_Xucgst0EqVqEjKgYvl9c4qDrt2antbcuPKY_BqPAkbEiIOnCzN9_k3oxmEnlDyihJGX6_6KieyyG_uoQnNGclEScR9NCGEsYxJxh-i4xhXhBBOGT9CR6UUpaR0gn7KbD7UMdk0JGiwdg3OpzI7s_Gf6hkEe6uTvYWIfYuvg22sgze_vv_A8wQBfIQOzJbj-calJUQbp_jCjUyPZe_wnU3Lv__w1dLH9dKHTacjTP_0tA5_til4PHPbpr0PeLYNtGnzCD1odRfh8f49Qdfv3y1Oz7PLjx8uTmeXmeZFkbKWVIaRpqx1WReQUyoFoy01dVuZsq1q0Jxq1gJreGlkzYUQtdRQGSEkbSvCT9CLXe46-JsBYlK9jQa6TjvwQ1RFSTipiBzFlzvRBB9jgFatg-112ChK1PYc6nCO0X26Dx3qHpqDud__yJ_tuY5Gd23Qzth40DgRJa3YqGU7zcYE3w5Yh69KFrzI1eJqrt4uzhefxBeitiM-3_naRLXyQ3Dj5v4z3m-1xrGH</recordid><startdate>19960412</startdate><enddate>19960412</enddate><creator>Felczak, Krzysztof</creator><creator>Drabikowska, Alicja K</creator><creator>Vilpo, Juhani A</creator><creator>Kulikowski, Tadeusz</creator><creator>Shugar, David</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960412</creationdate><title>6-Substituted and 5,6-Disubstituted Derivatives of Uridine: Stereoselective Synthesis, Interaction with Uridine Phosphorylase, and in Vitro Antitumor Activity</title><author>Felczak, Krzysztof ; Drabikowska, Alicja K ; Vilpo, Juhani A ; Kulikowski, Tadeusz ; Shugar, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a377t-f09c20d8ba8b7e5116421f1cbf9c8f9bea31a2fe2d38c6b3444b6ae9c4461f903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>General aspects</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Molecular Conformation</topic><topic>Pharmacology. Drug treatments</topic><topic>Structure-Activity Relationship</topic><topic>Tumor Cells, Cultured</topic><topic>Uridine - chemical synthesis</topic><topic>Uridine - chemistry</topic><topic>Uridine - pharmacology</topic><topic>Uridine Phosphorylase - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Felczak, Krzysztof</creatorcontrib><creatorcontrib>Drabikowska, Alicja K</creatorcontrib><creatorcontrib>Vilpo, Juhani A</creatorcontrib><creatorcontrib>Kulikowski, Tadeusz</creatorcontrib><creatorcontrib>Shugar, David</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Felczak, Krzysztof</au><au>Drabikowska, Alicja K</au><au>Vilpo, Juhani A</au><au>Kulikowski, Tadeusz</au><au>Shugar, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>6-Substituted and 5,6-Disubstituted Derivatives of Uridine: Stereoselective Synthesis, Interaction with Uridine Phosphorylase, and in Vitro Antitumor Activity</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1996-04-12</date><risdate>1996</risdate><volume>39</volume><issue>8</issue><spage>1720</spage><epage>1728</epage><pages>1720-1728</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Stereoselective procedures are described for the synthesis of 6-alkyluridines by Lewis acid-catalyzed condensation of (a) trimethylsilylated 6-alkyl-4-alkylthiouracils with 1-O-acetyl-2,3,5-tri-O-benzoyl-β-d-ribofuranose (ABR) and (b) trimethylsilylated 6-alkyl-3-benzyluracils with ABR. The 4-methylthio group was subsequently removed with the use of 1 N trifluoroacetic acid and the 3-benzyl group by a new modified procedure with the use of the complex BBr3-THF. Furthermore, 6-(hydroxymethyl)uridine (39) and 5-fluoro-6-(hydroxymethyl)uridine (40) were obtained by sequential oxidation with SeO2 and reduction with tetrabutylammonium borohydride of the 6-methyl group of 6-methyluridine (5) and 5-fluoro-6-methyluridine (35), and their corresponding 6-fluoromethyl congeners 41 and 42 were obtained by DAST treatment of 39 and 40, respectively. For all the foregoing nucleosides in the fixed syn conformation about the glycosyl bond, 1H NMR spectroscopy further demonstrated that the pentose rings exist predominantly in the conformation N (3‘-endo). Most of the nucleosides were weak substrates of Escherichia coli pyrimidine nucleoside phosphorylase. Enhanced susceptibility to phosphorolysis was exhibited by two of them, 39 and 41, with 6-CH2OH and 6-CH2F substituents capable of formation of an additional hydrogen bond with the enzyme. The 5-fluoro-6-substituted uridines were the poorest substrates. Cytotoxicities of the nucleosides were examined vs the human tumor cell lines MOLT-3, U-937, K-562, and IM-9, as well as PHA-stimulated human lymphocytes. Two of the analogues, 5-fluoro-6-(fluoromethyl)uridine (42) and 5-fluoro-6-(hydroxymethyl)uridine (40), exhibited cytotoxicities comparable to that of 5-fluorouracil.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>8648611</pmid><doi>10.1021/jm950675q</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 1996-04, Vol.39 (8), p.1720-1728 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_proquest_miscellaneous_78030906 |
source | American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list) |
subjects | Antineoplastic agents Antineoplastic Agents - chemical synthesis Antineoplastic Agents - pharmacology Biological and medical sciences General aspects Humans Medical sciences Molecular Conformation Pharmacology. Drug treatments Structure-Activity Relationship Tumor Cells, Cultured Uridine - chemical synthesis Uridine - chemistry Uridine - pharmacology Uridine Phosphorylase - metabolism |
title | 6-Substituted and 5,6-Disubstituted Derivatives of Uridine: Stereoselective Synthesis, Interaction with Uridine Phosphorylase, and in Vitro Antitumor Activity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T04%3A14%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=6-Substituted%20and%205,6-Disubstituted%20Derivatives%20of%20Uridine:%E2%80%89%20Stereoselective%20Synthesis,%20Interaction%20with%20Uridine%20Phosphorylase,%20and%20in%20Vitro%20Antitumor%20Activity&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Felczak,%20Krzysztof&rft.date=1996-04-12&rft.volume=39&rft.issue=8&rft.spage=1720&rft.epage=1728&rft.pages=1720-1728&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm950675q&rft_dat=%3Cproquest_cross%3E78030906%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a377t-f09c20d8ba8b7e5116421f1cbf9c8f9bea31a2fe2d38c6b3444b6ae9c4461f903%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78030906&rft_id=info:pmid/8648611&rfr_iscdi=true |